|
Premium Company Profile - Tanox (Datamonitor)
Market: Healthcare and Medical
Published Date: 09/01/2008
Market Research Report Title: Premium Company Profile - Tanox
Table of Contents: View
Report Type: Company Profile
Country: Global
Number of Pages: 35
|
Enquire about Report |
Summary: Introduction
Tanox identifies and develops therapeutic monoclonal antibodies to address significant unmet medical needs in the areas of immunology, infectious diseases and cancer. In January 2007, the stockholders of Tanox approved the merger with Genentech for $20 per share for a total cash value of approximately $919 million
Scope
Contains corporate strategy, value chain presence and SWOT AnalysisProvides detailed business description, segment analysis, 5-year financial trends, key products and key competitorsIncludes information on suppliers/ partners, shareholding structure and key employees with biographiesHighlights
Tanox is a biopharmaceutical company focused on discovering and developing therapeutic monoclonal antibodies that influence or are derived from the immune system.The company′s therapeutic emphasis is on the areas of immunology (asthma/allergy and autoimmune diseases), infectious diseases, and oncology.Tanox derives its revenues from royalties, license fees, development and manufacturing right, and profit sharing for its humanized monoclonal antibody product, Xolair.Reasons to Purchase
Access all the important information and analysis on the company in a single reportUnderstand company′s strengths, weaknesses, opportunities and threats along with business strategy and value chainGain access to company′s adjusted five year financial data along with key ratios and market capitalization
Reports are normally delivered on the same day, via email, if purchased by debit/credit card. Reports purchased by invoice will be released when payment has been received. When you place an order through Google Checkout, Google Checkout will display a price approximation in your local currency. Keep in mind that you'll still be charged in the currency displayed on companiesandmarkets.com. Your debit/credit card company might convert the charge to your local currency and may also add additional fees that are not reflected in the approximate price displayed.
www.companiesandmarkets.com is a central source of market research reports from the world’s leading analysts and report publishers. Companiesandmarkets.com contains a comprehensive range of specialised market research reports from leading publishers for all market sectors.
